HD-OPM Archive
Topics › Inflammation & CRP

Omega-3 1.8 g/day raised resolution markers and cut IL-6 in obese patients in 8-week RCT

Gokhan Can · Jul 12, 2024 · ♥ 1 reactions · 3 comments · original Facebook post
Inflammation & CRPSupplements & vitaminsWeight, visceral & liver fat
AI summary & key facts

In a double-blind trial of 40 people with obesity (21 omega-3, 19 placebo), 1.8 g/day omega-3 for 8 weeks raised Resolvin D1 and IL-10 and lowered IL-6 and MCP-1 compared with placebo. The trial is small, short and a preprint.

Omega-3 Fatty Acid Supplementation Enhances Inflammation Resolution in Obese Patients: Results from an 8-Week Randomized Controlled Trial

Obesity is associated with chronic low-grade inflammation. Polyunsaturated fatty acids such as omega-3 (n-3), are essential in the pro-resolution of inflammation. An 8-week double-blind randomized clinical trial was conducted with a n-6:n-3, 5:1 ratio, along with daily 1.8 g of n-3 supplementation vs. placebo. A total of 40 subjects were included, 21 in omega 3 group and 19 in placebo group.

The n-3 supplementation had a superior effect compared to placebo increasing levels of Resolvin D1 [129.3 (-90.1 - 193.5) vs. -16.8 (-237.8 - 92.5) pg/mL, p=0.041], IL-10 [1.4 (-0.7 - 4.6) vs. -2.0 (-5 - 0.05) pg/mL, p=0.001], and decreasing IL-6 [-0.67 (2.72 - -0.59) vs. 0.03 (-0.59 - 1.84) pg/mL p=0.015], and MCP-1 [-29.6 (-94.9 - 5.50) vs. 18.3 (-97.3 - 66.35) pg/mL, p=0.040]. In conclusion, n-3 supplementation promoted resolution of inflammation by increasing sys-temic levels of Resolvin D1, IL-10, and decreasing IL-6 and MCP-1.

preprints.orgLink to preprints.orgObesity is associated with chronic low-grade inflammation. Polyunsaturated fatty ac-ids such as omega-3 (n-3), are essential in the pro-resolution of inflammation. An 8-week double-blind randomized clinical trial was conducted with a n-6:n-3, 5:1 ratio, along with daily 1.8 g of n-3 supplementation....preprints.org

Research cited

#omega3#inflammation#obesity
← newer: Quote: evolution did not select for longer lives (Peter Diamolder: Ezetimibe linked to over 7-fold lower Alzheimer's and relate →